Cell Banking Outsourcing Market Size Report 2026, Size, Outlook

What Market Size Is Projected For The Cell Banking Outsourcing Market By 2030?
The cell banking outsourcing market size has grown rapidly in recent years. It will grow from $12.86 billion in 2025 to $14.76 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to growth in biologics manufacturing, increasing reliance on outsourced bioprocessing services, expansion of vaccine production programs, rising need for standardized cell line storage, cost optimization by pharmaceutical companies.

The cell banking outsourcing market size is expected to see rapid growth in the next few years. It will grow to $24.12 billion in 2030 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to surge in cell and gene therapy pipelines, rising demand for viral vector manufacturing, increasing regulatory focus on cell line traceability, growth of personalized medicine development, expansion of contract development and manufacturing organizations. Major trends in the forecast period include rising outsourcing of gmp-compliant cell banking services, increasing demand for multi-species cell banking capabilities, standardization of cell line documentation and traceability, expansion of viral and vector cell banking for advanced therapies, growing preference for long-term cell bank storage agreements.

Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

Which Primary Market Drivers Are Fueling Momentum In The Cell Banking Outsourcing Market?
The rise in the burden of chronic diseases is expected to propel the growth of the cell banking outsourcing market going forward. Chronic diseases are long-lasting medical conditions that develop gradually and persist over extended periods, often requiring ongoing management. The increasing burden of chronic diseases is driven by lifestyle changes, aging populations, and genetic predispositions. The cell banking outsourcing market supports chronic disease research by providing specialized infrastructure, advanced technologies, and expert capabilities that enable efficient storage, preservation, and processing of cellular materials used in therapeutic development. For instance, in April 2025, according to the NHS Confederation, a UK-based national association, in 2035, it is estimated that 17% of the UK population could be living with four or more chronic conditions. Therefore, the rise in the burden of chronic diseases is driving the growth of the cell banking outsourcing market.

What Major Market Segments Contribute To Shaping The Overall Framework Of The Cell Banking Outsourcing Market?
The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking
2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking
3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:
1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank
2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank
3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What New Trends Are Beginning To Take Shape Within The Cell Banking Outsourcing Market?
Major companies operating in the cell banking outsourcing market are focusing on developing technologically advanced solutions, such as single-cell potency characterization platforms, to deliver more precise potency assessments and support the development of high-quality cell therapies. A single-cell potency characterization platform refers to an advanced analytical system designed to evaluate the functional capabilities and therapeutic potential of individual cells within heterogeneous cell populations, enabling deeper insight into cell behavior, potency, and mechanism of action for research and clinical development. For instance, in January 2024, Cellply Srl, an Italy-based biotechnology company, launched VivaCyte, an end-to-end single-cell potency characterization platform that integrates potency analysis with immunophenotyping, featuring fully automated operation, single-cell resolution, and rapid multi-parameter functional assessment to reduce development time, cost, and risk while enabling comprehensive evaluation of multiple cell therapy candidates across diverse process options.

Who Are The Established And Emerging Players Expanding Their Footprint In The Cell Banking Outsourcing Market?
Major companies operating in the cell banking outsourcing market are Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Labcorp Drug Development, Covance Inc., SGS Life Sciences, Sartorius AG, BioReliance, Cleancells, Clean Biologics, Texcell, Goodwin Biotechnology Inc., Perfectus Biomed Limited, BioStorage Technologies Inc., Toxikon Corp., PX’Therapeutics SA, Sigma-Aldrich Co. Ltd., Transcell Biolife Pvt Ltd, Eurofins Scientific SE, ViruSure GmbH

Get Your In-Depth Cell Banking Outsourcing Market Report Now:
https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

Which Regional Clusters Are Forecasted To Outperform Others In The Cell Banking Outsourcing Market?
North America was the largest region in the cell banking outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company